Bluejay Diagnostics, Inc.
BJDX- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001704287
In the last 90 days, Bluejay Diagnostics, Inc. insiders filed 1 open-market purchase and 1 sale; 8 institutions reported holding it in 13F filings for Q2 2026, worth $259.3K in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Bluejay Diagnostics, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 10 | 11 | +1 |
| Shares | 136.8K | 178.7K | +42.0K (+30.7%) |
| Value | $55.7K | $47.4K | −$8.34K (−15.0%) |
New holders (4)
Institutions that held Bluejay Diagnostics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 29,907 | $8.00K | 0.00% |
| Two Sigma Securities, LLC | 27,094 | $7.12K | 0.00% |
| UBS Group AG | 5,158 | $1.36K | 0.00% |
| Coppell Advisory Solutions LLC | 12 | – | – |
Sold out (3)
Institutions that held Bluejay Diagnostics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Jane Street Group, LLC | 12,254 | $5.01K |
| Citadel Advisors LLC | 10,462 | $4.28K |
| Virtu Financial LLC | 10,031 | $4.00K |